menu search

GDTC / Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?

Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?
CytoMed Therapeutics (NASDAQ: GDTC ) stock is rocketing higher on Tuesday despite a lack of news concerning the company this morning. Instead of a press release of filing sending the shares higher, heavy trading is behind today's movement. Read More
Posted: Jul 11 2023, 08:15
Author Name: InvestorPlace
Views: 092074

GDTC News  

CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch

By Seeking Alpha
September 1, 2023

CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch

CytoMed Therapeutics is developing next-generation CAR-T cell therapies from γδ T cells for multiple solid tumor indications. The use of γδ T cell more_horizontal

Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?

By InvestorPlace
July 11, 2023

Why Is CytoMed Therapeutics (GDTC) Stock Up 157% Today?

CytoMed Therapeutics (NASDAQ: GDTC ) stock is rocketing higher on Tuesday despite a lack of news concerning the company this morning. Instead of a pre more_horizontal


Search within

Pages Search Results: